perfluorobutane has been researched along with Gastrointestinal Stromal Neoplasm in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ebihara, T; Ishida, Y; Kondo, S; Matsuda, R; Minami, T; Sato, S; Tanaka, T; Togo, G; Watanabe, Y; Yamada, A; Yamazaki, K; Yotsuya, S | 1 |
| Dote, K; Imai, H; Kamata, K; Kitano, M; Komaki, T; Kudo, M; Matsui, S; Sakamoto, H | 1 |
2 other study(ies) available for perfluorobutane and Gastrointestinal Stromal Neoplasm
| Article | Year |
|---|---|
[Successful treatment of a gastrointestinal stromal tumor with liver metastases in a case that tolerated imatinib administration, by radiofrequency ablation using contrast-enhanced ultrasonography].
Topics: Adult; Antineoplastic Agents; Benzamides; Catheter Ablation; Contrast Media; Drug Tolerance; Female; Ferric Compounds; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Iron; Liver Neoplasms; Oxides; Piperazines; Pyrimidines; Ultrasonography | 2010 |
Estimation of malignant potential of GI stromal tumors by contrast-enhanced harmonic EUS (with videos).
Topics: Biopsy, Fine-Needle; Contrast Media; Endosonography; Female; Ferric Compounds; Follow-Up Studies; Gastrointestinal Stromal Tumors; Humans; Infusions, Intravenous; Iron; Male; Middle Aged; Neoplasm Staging; Oxides; Prospective Studies; Reproducibility of Results; Sensitivity and Specificity; Ultrasonography, Doppler | 2011 |